Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy

La radiologia medica(2024)10.1007/s11547-024-01937-1Source: DataRank Database

Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy is a research paper published in La radiologia medica (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.49)OA: hybridTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (16)

Nicole Varble ORCID,Tabea Borde ORCID,Andrew S. Mikhail ORCID,Michael Kassin ORCID,Elliot Levy

Live enrichment

PubMed:39656418 PMC:PMC11870906 OpenAlex:https://openalex.org/W4405222489

Société Française de Radiologie

Grant: bourse de recherche Alain Rahmouni

National Institute of Biomedical Imaging and Bioengineering

National Institutes of Health Clinical Center

FWCI

0.49

Citation Percentile

0.6%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s11547-024-01937-1.pdf

HYBRIDhttps://doi.org/10.1007/s11547-024-01937-1

publisherhttps://link.springer.com/content/pdf/10.1007/s11547-024-01937-1.pdf

publisherhttps://link.springer.com/article/10.1007/s11547-024-01937-1/fulltext.html

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39656418

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisRadiomics and Machine Learning in Medical ImagingCholangiocarcinoma and Gallbladder Cancer StudiesMedicine

MeSH Terms

Immune Checkpoint InhibitorsAdultAgedAged, 80 and overContrast MediaFeasibility StudiesFemaleCarcinoma, HepatocellularHumansImmunotherapyLiver NeoplasmsMaleMiddle AgedRetrospective StudiesTomography, X-Ray ComputedChemoembolization, TherapeuticTreatment OutcomeResponse Evaluation Criteria in Solid Tumors

Keywords

MedicineOncologyCancer researchLiver neoplasmsImmunotherapyRetrospective studiesFollow-up studiesResponse Evaluation Criteria In Solid Tumors

Sustainable Development Goals

SDG 0: No poverty